Bill Kohlbrenner Email and Phone Number
Bill Kohlbrenner work email
- Valid
- Valid
- Valid
- Valid
Bill Kohlbrenner personal email
Bill Kohlbrenner phone numbers
Pharma industry veteran with extensive experience in drug discovery and business development. Transitioned to the biotech/medtech funding space to focus on helping promising early-stage companies find investment capital. Management experience as CEO of an early-stage company. Serve as an operational and BD consultant at early-stage companies and biotech organizations.
Boston-Based Newco
View-
Boston-Based NewcoGreater Boston Area
-
Chief Operating OfficerTheranovir Oct 2024 - PresentImmunotherapeutics for cancer and other diseases
-
Strategic Advisory BoardTheranovir Aug 2024 - Sep 2024
-
Strategic AdvisorBioloomics May 2024 - PresentAdvising the company on matters related to corporate strategy and business development -
Vice President Of Drug DevelopmentBioloomics Jan 2022 - May 2024BioLoomics is an early-stage technology company that has developed a novel platform for selectively delivering high levels of biologic drugs to cancer cells. This tech has the potential to achieve significantly enhanced safety and efficacy in treating select cancers.
-
Vice President Of Business DevelopmentBioloomics Aug 2021 - Dec 2021
-
Strategic Advisory Board MemberZylem Biosciences Nov 2023 - PresentChicago, Illinois, UsZylem Biosciences is a preclinical-stage biotech company that is advancing novel therapeutics for cancer and other serious diseases based on proprietary nanoparticle HDL mimetics that can achieve rapid cell entry and payload delivery. -
Technical And Strategic AdvisorLife Science Nation May 2021 - PresentCambridge, Ma, Us -
Chief Scientific OfficerLife Science Nation Aug 2014 - Apr 2021Cambridge, Ma, UsLife Science Nation (LSN) is a Boston-based company that offers a uniquely differentiated suite of services for emerging life science companies that include consulting support for fundraising, investor databases and the RESI partnering conference series. LSN works with early-stage biotech and medtech companies to position them for successful fundraising transactions.
-
CeoNeurolucent Aug 2017 - Jun 2021NeuroLucent was an early-stage company focused on developing small-molecule therapeutics to treat the cognitive loss associated with Alzheimer's disease.
-
Chief Development AdvisorNeurolucent Dec 2016 - Aug 2017Served as a consultant to help guide the development of NeuroLucent's drug discovery program.
-
Working Group MemberFifth Pcast Assessment Of The National Nanotechnology Initiative Feb 2014 - Aug 2014Member of a working group assembled by the President’s Council of Advisors on Science and Technology (PCAST) to conduct the fifth legislatively mandated strategic assessment of the National Nanotechnology Initiative
-
Director, Global External Research / Scientific AssessmentAbbvie Jan 2010 - Jun 2014North Chicago, Illinois, UsResponsible for developing and implementing a strategy for accessing external innovation to expand the early-stage Discovery pipeline. Headed the Technology Scouting Team that was focused on the identification and pursuit of technical opportunities world-wide. Played an operational role as a global scout for opportunities in China and Brazil. Beyond technology scouting, was involved with external drug discovery programs in established in Asia, precompetitive consortia and academic outreach with the goal of accessing novel targets, technologies and other know-how. -
Director, Cancer ResearchAbbott Laboratories Jan 2005 - Dec 2009Abbott Park, Illinois, UsLed a team involved in the exploration of novel therapeutic approaches and the identification of novel cancer targets. Conducted an internal strategic assessment the RNAi therapeutic space that led to a large in-house research effort, that was aligned with several external collaborations, focused on the identification of nanotechnology-based carriers for the delivery of novel siRNA cancer therapies. -
Director, Antiviral ResearchAbbott 1996 - 2004Abbott Park, Illinois, UsResponsible for the strategic direction of Abbott’s early antiviral drug discovery effort. The department included a large multi-disciplinary team of chemists and biologists focused on all aspects of small-molecule drug discovery, from target identification and screen development to late-stage medicinal chemistry efforts that yielded development candidates for treating HIV and HCV infections. In addition, the team successfully advanced major research efforts in other antiviral areas including influenza and Herpes viruses. Prior to 1996, held several technical and team management positions at Abbott and Pfizer (Groton) focused in the infectious diseases (antibiotic discovery) area.
Bill Kohlbrenner Skills
Frequently Asked Questions about Bill Kohlbrenner
What company does Bill Kohlbrenner work for?
Bill Kohlbrenner works for Boston-Based Newco
What is Bill Kohlbrenner's role at the current company?
Bill Kohlbrenner's current role is Pharma industry veteran | Biotech Advisor | Drug Discovery | Business Development.
What is Bill Kohlbrenner's email address?
Bill Kohlbrenner's email address is b.****@****ion.com
What is Bill Kohlbrenner's direct phone number?
Bill Kohlbrenner's direct phone number is +161760*****
What skills is Bill Kohlbrenner known for?
Bill Kohlbrenner has skills like Drug Discovery, Life Sciences, Biotechnology, Pharmaceutical Industry, Drug Development, Biochemistry, Technology Transfer, Oncology, Lifesciences, R&d, Chemistry, Strategy.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial